|
The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy Clinical research trials and The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy. The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy clinical trial. Participants oftentimes recieve the finest healthcare available for their The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy  The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
For Condition: Prostate Cancer
Status: Recruiting
Sponsor(s): Novartis Pharmaceuticals ,
Synopsis: The purpose of this study is to compare the effect of an investigational drug used intravenously and placebo administered every three months for one year, on bone loss associated with initial androgen deprivation) in men with prostate cancer without metastasis. In order to participate in this trial male patients must be 18 years of age or older and have been diagnosed with prostate cancer without metastasis and within one year of starting their androgen deprivation therapy at the day of randomization onto this trial. In addition, patients who have undergone a recent orchiectomy (or”ke-ek’te-me) (removal of one or two testes) are eligible to participate. Patients who received any prior bisphosphonate therapy or prior treatment with systemic corticosteroids within in the past 12 months are not eligible to participate. Also patients who are receiving treatment for osteoporosis are not eligible to participate. Inclusion into this clinical trial with this investigational drug is based on the protocol entry criteria and evaluation from a participating trial investigator.
Details:
Eligibility:
Study Type: Interventional,Prevention,Randomized,Double-Blind,Placebo Control,Parallel Assignment,Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Male
Protocol Entry Criteria: - Histologically confirmed diagnosis of carcinoma of the prostate - No distant metastases (stage TNMO) (ie. prostate cancer without metastases) - Patients within one year at the day of randomization from initiation of androgen deprivation therapy with a LHRH agonist (with or without an antiandrogen) and with the intended duration of androgen deprivation therapy of at least 12 months. Patients may also enter if they have received an orchiectomy (or”ke-ek’te-me) within two weeks of visit 1 - Patients who received any prior bisphosphonate therapy in the past 12 months will be excluded - Patients who are currently receiving diethylstilbesterol (DES) or PC-SPES (treatment for osteoporosis) will be excluded - Patients who have received prior treatment with systemic corticosteroids within the past 12 months will be excluded (short term corticosteroid therapy, e.g. to prevent/treat chemotherapy-induced nausea/vomiting or for acute illness like asthma exacerbation, is acceptable) - Other eligibility criteria may apply
Total Enrollment: 200
Location and Contact Information:
Atlantic Urological Medical Group *Recruiting*
Long Beach, California, 90806
United States
Recruiting Denise Mazzanti 562-595-5977
Morristown Memorial Hospital *Recruiting*
Morristown, New Jersey, 07962
United States
Recruiting Noreen Benjamin 973-971-6175
The Urology Clinic *Recruiting*
Portland, Oregon, 97210
United States
Recruiting Cindy Payne 503-279-8602
Triangle Urological Group *Recruiting*
Pittsburgh, Pennsylvania, 15212
United States
Recruiting Lori Merlotti 412-281-1757
Alaska Clinical Research Center *Recruiting*
Anchorage, Alaska, 99508
United States
Recruiting Sandie Michaelson 907-276-1455
Integrity Clinical Research, LLC *Recruiting*
Germantown, Tennessee, 38138
United States
Recruiting Melissa Minn 731-723-9703
Urology San Antonio Research *Recruiting*
San Antonio, Texas, 78229
United States
Recruiting Alex Amaya 210-617-4116
Millennium Therapeutics & Research *Recruiting*
Birmingham, Alabama, 35205
United States
Recruiting Linda Crumbley 205-930-8439
University of Miami School of Medicine, Dept. of Urology *Recruiting*
Miami, Florida, 33176
United States
Recruiting D. Bateman 305-243-7207
Staten Island Urological Research, PC *Recruiting*
Staten Island, New York, 10304
United States
Recruiting Nicole Zampardi 718-720-6040
The Urology Group *Recruiting*
Cincinnati, Ohio, 45212
United States
Recruiting Vicki Rice 513-366-3412
The Iowa Clinic, PC, Iowa Urology Research *Recruiting*
Des Moines, Iowa, 50309
United States
Recruiting Mary Lepic 515-241-5347
Albert Einstein Medical Center *Recruiting*
Philadelphia, Pennsylvania, 19141
United States
Recruiting Rosemary Sandy 215-456-1177
Carolina Urologic Research Center *Recruiting*
Myrtle Beach, South Carolina, 29572
United States
Recruiting Stacey Harrelson 843-839-1679
Western Clinical Research *Recruiting*
Torrance, California, 90505
United States
Recruiting Carolyn Ferguson 310-378-5003
Urologic Surgeons of New England, P.C. *Recruiting*
Providence, Rhode Island, 02904
United States
Recruiting Sue Hillman 401-274-6565
Albert Einstein Medical Center *Recruiting*
Philadelphia, Pennsylvania, 19141
United States
Recruiting Rosemary Sandy 215-456-1177
University Urological Research Institute *Recruiting*
Providence, Rhode Island, 02906
United States
Recruiting William Webb 401-331-9242
Arkansas Urology *Recruiting*
Little Rock, Arkansas, 72211
United States
Recruiting Anne Tursky 501-537-7867
San Diego Uro. Research *Recruiting*
San Diego, California, 92101
United States
Recruiting Patti Sanchez-Emery 619-236-0045
Medical Affiliated Research Center *Recruiting*
Huntsville, Alabama, 35801
United States
Recruiting Tammy Tucker 256-564-7175
Grove Hill Urology *Recruiting*
New Britain, Connecticut, 06052
United States
Recruiting Antonina Vaverchak 860-826-4453
Medisphere Medical Research Center, LLC *Recruiting*
Evansville, Indiana, 47714
United States
Recruiting Melinda Swanker 812-471-4110
Urological Associates, Inc. *Recruiting*
Columbus, Ohio, 43222
United States
Recruiting Brigit Duggan 614-221-5189
Connecticut Surgical Group *Recruiting*
Hartford, Connecticut, 06106
United States
Recruiting Christen Garcia 860-524-4328
Atlantic Urological Associates *Recruiting*
Daytona Beach, Florida, 32114
United States
Recruiting Sandra Warrington 386-239-8535
Urologic Associates of Allentown *Recruiting*
Allentown, Pennsylvania, 18103
United States
Recruiting Donna Beltz 610-437-4320
Summitt Clinical Research *Recruiting*
Owings Mills, Maryland, 21117
United States
Recruiting Karen Sellers 410-581-1600
Advanced Urology Med. Center *Recruiting*
Anaheim, California, 92801
United States
Recruiting Patricia Nunez 714-776-2030
Salt Lake Research *Recruiting*
Salt Lake City, Utah, 84124
United States
Recruiting Bianca Bevan 801-288-9778
AccuMed Research Associates *Recruiting*
Garden City, New York, 11530
United States
Recruiting Kerri Weingard 516-746-2190
Southeastern Urological Center, PA *Recruiting*
Tallahassee, Florida, 32308
United States
Recruiting Tammy Horton 850-201-0411
Millennium Medical Center *Recruiting*
Southfield, Michigan, 48075
United States
Recruiting Anthonia Zamishe 248-569-6700
Seattle Urological Associates *Recruiting*
Seattle, Washington, 98704
United States
Recruiting Jenni Liekkio 206-292-6488
Urosearch *Recruiting*
Ocala, Florida, 34470
United States
Recruiting Kathryn Goad 352-732-6040
Associates In Urology, LLC *Recruiting*
West Orange, New Jersey, 07052
United States
Recruiting Kit Murtha 973-325-6100
Advanced Research Institute, Inc. *Recruiting*
New Port Richey, Florida, 34652
United States
Recruiting Kristin White 727-842-9561
Quality Clinical Research LLC *Recruiting*
Springfield, Nebraska, 68059
United States
Recruiting Kim Ganzel 402-253-2738
Oregon Urology Specialists *Recruiting*
Eugene, Oregon, 97401
United States
Recruiting Caryl Wilson 541-284-5508
Donald Gleason, MD *Recruiting*
Tucson, Arizona, 85712
United States
Recruiting Peggy Gleason 520-323-9601
Rockwood Clinic *Recruiting*
Spokane, Washington, 99220
United States
Recruiting Krista Sander 509-838-2531
Advanced Clinical Therapeutics *Recruiting*
Tucson, Arizona, 85712
United States
Recruiting Peggy Gleason 520-323-9601
Urological Surgeons of L.I. *Recruiting*
Garden City, New York, 11530
United States
Recruiting Vincent Gandolfo 516-742-3200
Mount Vernon Urological Associates *Recruiting*
Mount Vernon, Ohio, 43050
United States
Recruiting Jamie Breckler 740-392-0657
Associated Urologic Specialist, PA *Recruiting*
Marlton, New Jersey, 08053
United States
Recruiting Beverly Pfeifer 856-985-4286
Additional Information:
Study ID Numbers: CZOL446GUS45; ZENITH
Study Start Date: April 2003
Record last reviewed: July 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00063609
Other Prostate Cancer Studies:
1. Gene-Environment Interaction in Prostate Cancer
2. A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy
3. Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma
4. Study Of MEDI-522 In Combination With Docetaxel ± Low-Dose Estramustine And Zoledronic Acid In The Treatment Of Patients With Androgen-Independent Prostate Cancer That Has Metastasized To Bone
5. Phase I/II Study of IV Estramustine Combined with Taxol in Patients with Hormone Refractory Adenocarcinoma of the Prostate
Related Studies:
Other Prostate Cancer Clinical Trials
Other Florida Clinical Trials
Other Miami Clinical Trials
The Effect of Zometa on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
|
|
|
|
|
|
|
|
